Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
141 hedge funds and large institutions have $297M invested in Vaxart in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 37 reducing their positions, and 17 closing their positions.
33% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $16.9M
30% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 37
14% more capital invested
Capital invested by funds: $260M → $297M (+$37.4M)
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
1.4% more ownership
Funds ownership: 28.45% → 29.86% (+1.4%)
1% less funds holding
Funds holding: 143 → 141 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$9.84M |
| 2 |
D.E. Shaw & Co
New York
|
+$9.22M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.34M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$949K |
| 5 |
Goldman Sachs
New York
|
+$941K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.07M |
| 2 |
Citigroup
New York
|
-$1.82M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$818K |
| 4 |
Squarepoint
New York
|
-$755K |
| 5 |
BlackRock
New York
|
-$607K |
VXRT Hedge Fund Activity: Q3 2021 in Review
141 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2021, worth a combined $297M — up 14% from $260M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new VXRT positions and 17 closed out — a net gain of 2 holders — while 48 added to existing stakes and 37 trimmed.
The largest buyer was State Street, adding an estimated $9.84M. The largest seller was Susquehanna International Group, cutting an estimated $3.07M.
- 141 institutional investors held Vaxart (VXRT) as of Q3 2021, down from 143 in Q2 2021.
- Funds reported $297M of Vaxart stock for Q3 2021, up 14% quarter-over-quarter.
- 19 funds opened new Vaxart positions in Q3 2021 and 17 closed out, a net change of +2 holders.
- The largest Vaxart buyer in Q3 2021 was State Street, an estimated $9.84M added.
- The largest Vaxart seller in Q3 2021 was Susquehanna International Group, an estimated $3.07M sold.
Based on aggregated 13F filings for Q3 2021.